Cargando…
Drugs acting on renin angiotensin system and use in ill patients with COVID-19
Some concerns about the prescription of drugs acting on the renin-angiotensin system (angiotensin-converting enzyme 1 (ACE1) inhibitors, ACEi; angiotensin II type 1 receptor blockers, ARB) have emerged due to SARS COV2 and COVID-19 pandemic. These very legitimate questions are directly the consequen...
Autores principales: | Alexandre, Joachim, Cracowski, Jean-Luc, Richard, Vincent, Bouhanick, Béatrice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238972/ https://www.ncbi.nlm.nih.gov/pubmed/32553503 http://dx.doi.org/10.1016/j.therap.2020.05.009 |
Ejemplares similares
-
Renin-angiotensin-aldosterone system and COVID-19 infection
por: Alexandre, Joachim, et al.
Publicado: (2020) -
DPP-4 inhibitors and severe course of illness in patients with COVID-19
por: Bouhanick, Béatrice, et al.
Publicado: (2021) -
Diabetes and COVID-19
por: Bouhanick, Béatrice, et al.
Publicado: (2020) -
Diabète et COVID-19
por: Bouhanick, Béatrice, et al.
Publicado: (2020) -
The use of drugs acting on the renin–angiotensin system and the incidence of pancreatic cancer
por: Mandilaras, Victoria, et al.
Publicado: (2017)